Targeting Oncoprotein Translation with Rocaglates in MYC-Driven Lymphoma

被引：2
|
作者：
Zhang, Xuan [1 ]
Bi, Chengfeng [1 ]
Lu, Ting [2 ]
Yue, Ting [3 ]
Zhang, Weiwei [1 ]
Zhang, Xiaoyan [4 ]
Cheng, Wang [1 ]
Tian, Tian [1 ]
Lunning, Matthew A. [1 ]
Vose, Julie M. [1 ]
Pelletier, Jerry [5 ]
Porco, John A., Jr. [6 ]
Tao, Jianguo [7 ]
Fu, Kai [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
[4] China Yixueke Xueyuan Hemopathy Hosp, Tianjin, Peoples R China
[5] McGill Univ, Montreal, PQ, Canada
[6] Boston Univ, Boston, MA 02215 USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117659
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
38
引用
收藏
页数：3
相关论文
共 50 条
  • [21] TARGETING GLUTAMINE METABOLISM AS A THERAPEUTIC STRATEGY IN MYC-DRIVEN MEDULLOBLASTOMA
    Hanaford, Allison
    Eberhart, Charles
    Archer, Tenley
    Tamayo, Pablo
    Pomeroy, Scott
    Raabe, Eric
    NEURO-ONCOLOGY, 2014, 16 : 94 - 94
  • [22] Targeting RNA polymerase I to treat MYC-driven cancer
    G Poortinga
    L M Quinn
    R D Hannan
    Oncogene, 2015, 34 : 403 - 412
  • [23] Targeting glutamine metabolism as a therapeutic strategy in MYC-driven medulloblastoma
    Hanaford, Allison Rose
    Eberhart, Charles G.
    Raabe, Eric H.
    CANCER RESEARCH, 2014, 74 (19)
  • [24] DUAL TARGETING OF PROCESSIVE TRANSCRIPTION FOR MYC-DRIVEN CIRCUITRY IN MEDULLOBLASTOMA
    Walker, Faye M.
    Madhavan, Krishna
    Sobral, Lays Martin
    Donthula, Sahiti
    Balakrishnan, Ilango
    Wang, Dong
    Pierce, Angela
    Veo, Bethany
    Karam, Sana D.
    Serkova, Natalie J.
    Foreman, Nicholas K.
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    Dahl, Nathan A.
    NEURO-ONCOLOGY, 2024, 26
  • [25] Targeting RNA polymerase I to treat MYC-driven cancer
    Poortinga, G.
    Quinn, L. M.
    Hannan, R. D.
    ONCOGENE, 2015, 34 (04) : 403 - 412
  • [26] PCYT1A in MYC-Driven Lymphoma: Role on Aberrant Choline Metabolism and Therapeutic Targeting By Berberine
    Xiong, Jie
    Wang, Li
    Zhao, Weili
    BLOOD, 2015, 126 (23)
  • [27] An oncoprotein CREPT functions as a co-factor in MYC-driven transformation and tumor growth
    Li, Mengdi
    Li, Jingya
    He, Chunhua
    Jiang, Guancheng
    Ma, Danhui
    Guan, Haipeng
    Lin, Yuting
    Li, Meng
    Jia, Jing
    Duan, Xiaolin
    Wang, Yinyin
    Ren, Fangli
    Li, Haitao
    Wang, Xiaoguang
    Cao, Chenxi
    Chang, Zhijie
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2025, 301 (01)
  • [28] Targeting MYC-Driven B-Cell Lymphoma By Inhibition of the Histone Methyltransferase DOT1L
    Deshpande, Anagha
    Chen, Benson
    Ramezani-Rad, Parham
    Pastore, Alessandro
    Zhao, Luyi
    Weigert, Oliver
    Armstrong, Scott A.
    Rickert, Robert C.
    Ren, Bing
    Deshpande, Aniruddha J.
    BLOOD, 2018, 132
  • [29] Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
    Ferrao, P. T.
    Bukczynska, E. P.
    Johnstone, R. W.
    McArthur, G. A.
    ONCOGENE, 2012, 31 (13) : 1661 - 1672
  • [30] Synergistic targeting of CHK1 and mTOR in MYC-driven tumors
    Song, Xiaoxue
    Wang, Liyuan
    Wang, Tianci
    Hu, Juncheng
    Wang, Jingchao
    Tu, Rongfu
    Su, Hexiu
    Jiang, Jue
    Qing, Guoliang
    Liu, Hudan
    CARCINOGENESIS, 2021, 42 (03) : 448 - 460
12345